283 related articles for article (PubMed ID: 31039577)
1. Nonsteroidal Anti-Inflammatory Drugs: A Potential Pharmacological Treatment for Intracranial Aneurysm.
Fisher CL; Demel SL
Cerebrovasc Dis Extra; 2019; 9(1):31-45. PubMed ID: 31039577
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory changes in the aneurysm wall: a review.
Tulamo R; Frösen J; Hernesniemi J; Niemelä M
J Neurointerv Surg; 2018 Jul; 10(Suppl 1):i58-i67. PubMed ID: 30037960
[TBL] [Abstract][Full Text] [Related]
3. Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms.
Frösen J; Cebral J; Robertson AM; Aoki T
Neurosurg Focus; 2019 Jul; 47(1):E21. PubMed ID: 31261126
[TBL] [Abstract][Full Text] [Related]
4. Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.
Starke RM; Chalouhi N; Ding D; Hasan DM
Cerebrovasc Dis; 2015; 39(5-6):332-42. PubMed ID: 25967073
[TBL] [Abstract][Full Text] [Related]
5. Prevention Effect of Antiplatelets on Aneurysm Rupture in a Mouse Intracranial Aneurysm Model.
Suzuki T; Kamio Y; Makino H; Hokamura K; Kimura T; Yamasaki T; Hiramatsu H; Umemura K; Namba H
Cerebrovasc Dis; 2018; 45(3-4):180-186. PubMed ID: 29614486
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory changes in the aneurysm wall: a review.
Tulamo R; Frösen J; Hernesniemi J; Niemelä M
J Neurointerv Surg; 2010 Jun; 2(2):120-30. PubMed ID: 21990591
[TBL] [Abstract][Full Text] [Related]
7. Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results.
Hasan DM; Chalouhi N; Jabbour P; Dumont AS; Kung DK; Magnotta VA; Young WL; Hashimoto T; Richard Winn H; Heistad D
J Am Heart Assoc; 2013 Feb; 2(1):e000019. PubMed ID: 23525414
[TBL] [Abstract][Full Text] [Related]
8. Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation.
Aoki T; Fukuda M; Nishimura M; Nozaki K; Narumiya S
Acta Neuropathol Commun; 2014 Mar; 2():34. PubMed ID: 24685329
[TBL] [Abstract][Full Text] [Related]
9. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture.
Jayaraman T; Paget A; Shin YS; Li X; Mayer J; Chaudhry H; Niimi Y; Silane M; Berenstein A
Vasc Health Risk Manag; 2008; 4(4):805-17. PubMed ID: 19065997
[TBL] [Abstract][Full Text] [Related]
11. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
12. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
13. The Role of NF-κB in Intracranial Aneurysm Pathogenesis: A Systematic Review.
Khan D; Cornelius JF; Muhammad S
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762520
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy.
Radu BM; Epureanu FB; Radu M; Fabene PF; Bertini G
Epilepsy Res; 2017 Mar; 131():15-27. PubMed ID: 28212985
[TBL] [Abstract][Full Text] [Related]
15. Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.
Chalouhi N; Starke RM; Correa T; Jabbour PM; Zanaty M; Brown RD; Torner JC; Hasan DM
Hypertension; 2016 Aug; 68(2):411-7. PubMed ID: 27296993
[TBL] [Abstract][Full Text] [Related]
16. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of intracranial aneurysm and aortic dissection in hypertensive rat treated with the prostaglandin F-receptor antagonist AS604872.
Fukuda M; Aoki T; Manabe T; Maekawa A; Shirakawa T; Kataoka H; Takagi Y; Miyamoto S; Narumiya S
J Pharmacol Sci; 2014; 126(3):230-42. PubMed ID: 25341845
[TBL] [Abstract][Full Text] [Related]
18. Risk factor management matters more than pharmaceutical cyclooxygenase-2 inhibition in the prevention of de novo intracranial aneurysms.
Räisänen S; Huttunen J; Huuskonen TJ; von Und Zu Fraunberg M; Koivisto T; Jääskeläinen JE; Lindgren A; Frösen J
Eur J Neurol; 2022 Sep; 29(9):2734-2743. PubMed ID: 35678735
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms.
Aoki T; Frȍsen J; Fukuda M; Bando K; Shioi G; Tsuji K; Ollikainen E; Nozaki K; Laakkonen J; Narumiya S
Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174280
[TBL] [Abstract][Full Text] [Related]
20. Biology of intracranial aneurysms: role of inflammation.
Chalouhi N; Ali MS; Jabbour PM; Tjoumakaris SI; Gonzalez LF; Rosenwasser RH; Koch WJ; Dumont AS
J Cereb Blood Flow Metab; 2012 Sep; 32(9):1659-76. PubMed ID: 22781330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
